LAUDICELLA, Riccardo
 Distribuzione geografica
Continente #
EU - Europa 1.307
NA - Nord America 1.140
AS - Asia 345
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.795
Nazione #
US - Stati Uniti d'America 1.128
IE - Irlanda 419
SE - Svezia 370
IT - Italia 293
SG - Singapore 146
CN - Cina 114
DE - Germania 53
IN - India 50
PL - Polonia 50
FR - Francia 25
FI - Finlandia 24
GB - Regno Unito 24
BE - Belgio 21
ID - Indonesia 12
CA - Canada 10
LT - Lituania 10
VN - Vietnam 8
IR - Iran 6
NL - Olanda 5
AT - Austria 4
TR - Turchia 4
ES - Italia 3
MX - Messico 2
RO - Romania 2
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EU - Europa 1
HK - Hong Kong 1
JP - Giappone 1
MK - Macedonia 1
MU - Mauritius 1
PH - Filippine 1
TW - Taiwan 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 2.795
Città #
Dublin 417
Chandler 413
Nyköping 288
Singapore 114
Messina 80
Princeton 74
Ashburn 68
Medford 61
Warsaw 50
Bremen 37
Des Moines 35
Beijing 30
Rome 28
Hyderabad 27
Helsinki 23
Brussels 21
Jacksonville 19
Dearborn 17
Los Angeles 15
Palermo 14
Boardman 12
Jakarta 12
Jinan 12
Ann Arbor 10
Pune 10
Genoa 9
Mumbai 9
Dong Ket 8
Nanjing 8
London 7
Nanchang 7
Seattle 7
Wilmington 7
Hangzhou 6
Munich 6
Redwood City 6
Shenyang 6
Tianjin 6
Milan 5
Ottawa 5
Santa Domenica 5
Torregrotta 5
Cagliari 4
Cambridge 4
Florence 4
Fuzhou 4
Istanbul 4
San Mateo 4
Toronto 4
Vienna 4
Waverly Hall 4
Zhengzhou 4
Augusta 3
Changsha 3
Frankfurt am Main 3
Haikou 3
Mislata 3
Qingdao 3
Rometta Marea 3
Taiyuan 3
Taizhou 3
Bari 2
Bologna 2
Catania 2
Chengdu 2
Chicago 2
Edinburgh 2
Fairfield 2
Fara Gera d'Adda 2
Fiumefreddo Di Sicilia 2
Hebei 2
Iasi 2
Lanzhou 2
Lecce 2
Meppel 2
Monmouth Junction 2
Naples 2
New York 2
Padova 2
Pedara 2
Pleasant Hill 2
Pozzo Di Gotto 2
Pozzuoli 2
Quinto Di Treviso 2
Rambouillet 2
Reggio Calabria 2
Santa Clara 2
Santa Teresa Di Riva 2
The Dalles 2
Vittoria 2
Amsterdam 1
Ancona 1
Angeles City 1
Ardabil 1
Balestrate 1
Belpasso 1
Berlin 1
Brno 1
Brooklyn 1
Castelnuovo Rangone 1
Totale 2.134
Nome #
Artificial intelligence in molecular imaging: from machine to deep learning 122
PRRT Retreatments: Renal Function Evaluation 91
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 82
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 77
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 73
Safety, effectiveness and haematological toxicity of 223Radichloride: a single Centre experience 69
Complete Response in a Pancreatic Nen with Liver Metastasis after PRRT in association with Lanreotide Autogel/depot: Design of the Prelude Study 69
[68 Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177 Lu]DOTATOC PRRT: The “Theragnomics” Concept 67
Effectiveness, safety and haematological toxicity of 223Ra-Cl2: a single centre experience 66
Dual Time-Point FET-PET/CT in Glioma Patients: a Single-Centre Preliminary Experience 66
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 65
18F-FDG PET/CT Imaging of Immune Checkpoint Inhibitor-Related "Retroperitoneal Panniculitis" 63
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 62
Renal Function Evaluation in PRRT Retreatments 62
Clinico-laboratory response and haematological toxicity in patients undergoing therapy with 223RA-dichloride 60
A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy 60
223RA-dichloride use in patients affected by bone metastases from castration-resistant prostate cancer: single centre experience 59
Complete response in a pancreatic NEN with liver metastasis after PRRT in association with lanreotide autogel/depot 58
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 54
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study 53
COVID-19 Surface Persistence: A Recent Data Summary and Its Importance for Medical and Dental Settings 52
Non-invasive cardiac imaging in patients with systemic amyloidosis: a practical approach with emphasis on clinical contribution of bone-seeking radiotracers 49
18F-FACBC in prostate cancer: A systematic review and meta-analysis 49
Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature 48
Prognostic Validity of Dual Tracer PET/CT In The PRRT Enrollment of GEP-NET Patients 48
PRRT retreatments: renal function evaluation 48
Artifcial intelligence applications in SSTR targeted PET/CT images: prediction of response assessment in GEP-NETs undergoing PRRT with [177Lu]DOTATOC 48
Is dual tracer PET/CT a prognostic biomarker in the PRRT enrollment of GEP-NET patients? 47
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 47
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study 46
The utility of dual time-point FET-PET/CT in recurrence assessment of glioma patients 45
Correction to: 18F-FMISO PET imaging: insights over MRI in patients with glioma (Clinical and Translational Imaging, (2020), 8, 1, (3-10), 10.1007/s40336-019-00353-0) 44
18F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma 44
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature 41
Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination 40
[177Lu]Lu-DOTA-TATE versus standard of care in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): a cost-consequence analysis from an Italian hospital perspective 39
Prognostic insights of molecular imaging in cardiac sarcoidosis 39
Sars-cov-2 persistence: data summary up to q2 2020 39
Peptide Receptor Radionuclide Therapy of Pulmonary Neuroendocrine Neoplasms: a Single-Centre Experience 38
The additional value of 18F-FDG PET and MRI in patients with glioma: A review of the literature from 2015 to 2020 38
Artificial neural networks in cardiovascular diseases and its potential for clinical application in molecular imaging 37
Artificial intelligence applications in 68Ga-DOTA PETICT images: Prediction of response assessment in GEP-NETs undergoing PRRT with 177Lu-DOTATOC 37
Imaging gastrin-releasing peptide receptors (GRPRs) in prostate cancer 35
[18F] Fluorothymidine Positron Emission Tomography Imaging in Primary Brain Tumours: A Systematic Review 34
Combined use of peptide receptor radionuclide therapy and metronomic chemotherapy in neuroendocrine tumors: a possible choice driven by nuclear medicine molecular imaging 34
Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas 32
Artificial Intelligence Applications on Restaging [18F]FDG PET/CT in Metastatic Colorectal Cancer: A Preliminary Report of Morpho-Functional Radiomics Classification for Prediction of Disease Outcome 30
PET/MR in neuro-oncology: is it ready for prime-time? 29
Radiomics Analysis of Brain [18 F]FDG PET/CT to Predict Alzheimer’s Disease in Patients with Amyloid PET Positivity: A Preliminary Report on the Application of SPM Cortical Segmentation, Pyradiomics and Machine-Learning Analysis 28
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 27
Malignant cutaneous melanoma: Updates in PET imaging 27
Undetectable or low (< 1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients 26
Prostate Cancer Biochemical Recurrence Resulted Negative on [68Ga]Ga-PSMA-11 but Positive on [18F]Fluoromethylcholine PET/CT 24
The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence Also in Comparison with MRI 24
null 23
Emerging applications of imaging in glioma: focus on PET/MRI and radiomics 22
The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients 21
Molecular imaging of pancreatic neoplasms 21
Response prediction to PRRT in progressing and metastatic GEP-NET undergoing restaging 68Ga-DOTA PETICT: A preliminary multicenter radiomics study 21
Preliminary Findings of the Role of FAPi in Prostate Cancer Theranostics 21
null 16
Recombinant human thyrotropin (rhTSH) versus Levo-thyroxine withdrawal in radioiodine therapy of differentiated thyroid cancer patients: differences in abdominal absorbed dose 15
Monitoring of cardiac transthyretin amyloid load by [Tc-99m]DPD scintigraphy: is it the end of the semi-quantitative evaluation? 14
Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics 13
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 13
The role of PET radiomic features in prostate cancer: a systematic review 12
PET-based artificial intelligence applications in cardiac nuclear medicine 8
Artificial intelligence in molecular imaging: from machine to deep learning 7
PET Imaging in Gliomas: Clinical Principles and Synergies with MRI 6
The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers 6
The Added Value of [18F]Choline PET/CT in Low-Risk Prostate Cancer Staging: A Case Report 3
mCRPC progression of disease after [177Lu]Lu-PSMA-617 detected on [18F]Choline: a case of PCa heterogeneity 3
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature 3
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study 3
An Overview of In Vitro Assays of 64Cu-, 68Ga-, 125I-, and 99mTc-Labelled Radiopharmaceuticals Using Radiometric Counters in the Era of Radiotheranostics 2
[18F]FDG PET/CT criteria for treatment response assessment: EORTC and beyond 2
FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature 2
[11C]Choline PET/CT in a Patient with Prostate Cancer Biochemical Recurrence Showing Two Suspicious Findings in the Breast and Liver 2
Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patients 2
Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI 2
The Homunculus of unspecific bone uptakes associated with PSMA-targeted tracers: a systematic review-based definition 1
Clinical Applications of Immuno-PET in Lymphoma: A Systematic Review 1
PSMA-positive prostatic volume prediction with deep learning based on T2-weighted MRI 1
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature 1
A Multimodal Clinical Approach for the Treatment of Bone Metastases in Solid Tumors 1
Prostate-Specific Membrane Antigen Positron Emission Tomography Oncological Applications beyond Prostate Cancer in Comparison to Other Radiopharmaceuticals 1
ChatGPT in nuclear medicine and radiology: lights and shadows in the AI bionetwork 1
Correction: PSMA‑positive prostatic volume prediction with deep learning based on T2‑weighted MRI 1
Reply to Perera Molligoda Arachchige AS [1] 1
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score 1
Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [18F]PSMA-1007 PET/CT 1
Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives 1
A Review of Advances in Molecular Imaging of Rheumatoid Arthritis: From In Vitro to Clinic Applications Using Radiolabeled Targeting Vectors with Technetium-99m 1
Combined forced diuresis and late acquisition on [68Ga]Ga-PSMA-11 PET/CT for biochemical recurrent prostate cancer: a clinical practice-oriented study 1
Applications of Artificial Intelligence and Radiomics in Molecular Hybrid Imaging and Theragnostics for Neuro-Endocrine Neoplasms (NENs) 1
68Ga-PSMA-11 PET/MRI versus multiparametric MRI in men referred for prostate biopsy: primary tumour localization and interreader agreement 1
Is There a Role of Interim PSMA PET in Chemotherapy of Prostate Cancer? 1
Can We Predict Skeletal Lesion on Bone Scan Based on Quantitative PSMA PET/CT Features? 1
Totale 2.972
Categoria #
all - tutte 16.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202098 0 0 0 0 0 15 9 8 3 23 11 29
2020/2021259 22 5 60 6 29 13 12 14 43 27 17 11
2021/2022464 6 30 4 22 31 13 27 34 6 54 35 202
2022/20231.387 119 196 70 107 91 140 17 89 482 16 36 24
2023/2024369 41 39 22 33 43 50 13 31 9 32 16 40
2024/2025348 12 59 45 75 153 4 0 0 0 0 0 0
Totale 2.972